---
title: "Apogee Therapeutics, Inc. (APGE.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/APGE.US.md"
symbol: "APGE.US"
name: "Apogee Therapeutics, Inc."
industry: "Biotechnology"
---

# Apogee Therapeutics, Inc. (APGE.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.apogeetherapeutics.com](https://www.apogeetherapeutics.com) |

## Company Profile

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG77...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -18.42 | 499/604 | - | - | - |
| PB | 7.97 | 356/604 | 7.96 | 3.61 | 3.20 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-20T05:00:00.000Z

Total Analysts: **17**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 14 | 82% |
| Overweight | 0 | 0% |
| Hold | 2 | 12% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 68.39 |
| Highest Target | 137.00 |
| Lowest Target | 83.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/APGE.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/APGE.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/APGE.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.